Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-seq of Ishikawa and KLE cells following CuCl₂ treatment

ABSTRACT: We conducted bulk RNA-seq analyses for both Ishikawa and KLE cells, comparing untreated control cells with those treated with CuCl₂ (200 μM).

ORGANISM(S): Homo sapiens

PROVIDER: GSE342605 | GEO | 2026/08/14

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

gRNA-seq from Ishikawa after medroxyprogesterone treatment

Project description:Hormone therapy serves as a primary choice for fertility preservation and is also considered for advanced and recurrent cases with endometrial cancer. While a number of patients fail to respond favorably to hormone treatments. In order to explore the mechanisms underpinning hormone resistance, Here we constructed a whole-genome library for EAC cell lines using the CRISPR-Cas9 system and performed high-throughput sequencing after medroxyprogesterone treatment in this study. For CRISPR screening, ishikawa cells were infected pooled GeCkov2 lentiviral library with functional MOI of 0.3. Genomic DNA from each group was isolated and amplified by PCR. The PCR products were purified and subjected to NGS by using the Novaseq 6000-PE150 platform. After 48h of puromycin selection, the cells were divided into three groups, the baseline group cells were collected and frozen at -80 degree centigrade, the control group cells were treated with DMSO for 10 days while the MPA group cells were treated with 15 μM MPA for 10 days.

2024-02-12 | GSE241070 | GEO

Analysis of gene expression change between Ishikawa-02 SC and Ishikawa-02 shSOX2

Project description:We collected total RNA from both Ishikawa-02 SC and Ishikawa-02 shSOX2 and examined mRNA expression profile, comprehensively.

2018-05-18 | GSE114582 | GEO

RNA-seq of Ishikawa and KLE cells following CuCl₂ treatment

Project description:RNA-seq of Ishikawa and KLE cells following CuCl₂ treatment

| PRJNA1508271 | ENA

gRNA-seq from Ishikawa after medroxyprogesterone treatment

Project description:gRNA-seq from Ishikawa after medroxyprogesterone treatment

| PRJNA1006344 | ENA

Ishikawa cell line LC-MS/MS analysis

Project description:The protein profile of Ishikawa cells, a widely used model for uterine lining cell studies, was examined. Additionally, we investigated potential disruptions caused by liposomes containing phosphatidylcholine and phosphatidylethanolamine, serving as models for drug delivery.

2024-08-17 | PXD050871 | Pride

Analysis of gene expression change between Ishikawa-02 SC and Ishikawa-02 shSOX2

Project description:Analysis of gene expression change between Ishikawa-02 SC and Ishikawa-02 shSOX2

| PRJNA471843 | ENA

Characterizing transcriptional responses of the Ishikawa cell line to ethinyl estradiol (EE; CAS #57-63-6) following 72 hour exposure

Project description:A toxicity pathway approach was taken to develop an in vitro assay using human uterine epithelial adenocarcinoma (Ishikawa) cells (ECACC cat#99040201) as a replacement for measuring an in vivo uterotrophic response to estrogens. As part of validating the use of this cell line, gene arrays were performed to confirm functional transcriptional responses to ethinyl estradiol (EE)

2017-07-01 | GSE84711 | GEO

RIP-sequence of IGF2BP3 in Ishikawa cells

Project description:RIP-sequence of IGF2BP3 in Ishikawa cells

| PRJNA816159 | ENA

polyA mRNA RNA-seq from Ishikawa (ENCSR000BYA)

Project description:RNA-seq on ECC-1 greater than 200bp polyA+ treated with dimethylsulfoxide for 4 hours. Note- This experiment previously referred to its biosample as ECC-1, however it has been found that all currently available ECC-1 are actually Ishikawa cells. For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

2017-02-03 | GSE93438 | GEO

RNA sequencing of LINC00958 silenced and LINC00958 non-silenced Ishikawa cells

Project description:To confirm the downstream genes of LINC00958, we employed RNA sequencing (RNA-seq) to identify the differentially expressed genes when LINC00958 was silenced in Ishikawa cells. The sample of LINC00958-silenced Ishikawa cells (sh-LINC00958, n=3) and negative control cells (sh-NC, n=2) were sent to Shanghai Sangon Biotech of China for library construction, sequencing, data preprocessing and gene mapping. Sequencing was performed on an DNBSEQ-T7 platform for the generation of raw data. Genes were considered significantly differentially expressed if the P value < 0.05 and |log2FC| > 1.The results showed that a total of 305 mRNAs were regulated after LINC00958 knockdown (fold change>2, P<0.05)

2022-03-16 | GSE198619 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data